{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:00:23Z","timestamp":1766023223154,"version":"3.48.0"},"reference-count":19,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/nhtj8584","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:12:41Z","timestamp":1745899961000},"page":"3001-3008","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic cerebellar degeneration combined with Lambert-Eaton myasthenia gravis syndrome in a patient positive for SOX1 antibody"],"prefix":"10.62347","volume":"17","author":[{"given":"Xianzhu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1471668","DOI":"10.3389\/fneur.2024.1471668","article-title":"Case report: an autopsy report of patient with metastatic brain tumor and carcinomatous meningitis mimicking paraneoplastic neurological syndrome","volume":"15","author":"Amano","year":"2024","unstructured":"Amano R, Sunouchi A, Yokota Y and Mochizuki K. Case report: an autopsy report of patient with metastatic brain tumor and carcinomatous meningitis mimicking paraneoplastic neurological syndrome. Front Neurol 2024; 15: 1471668.","journal-title":"Front Neurol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Abdulaziz ATA, Yu XQ, Zhang L, Jiang XY, Zhou D and Li JM. Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: case report. Medicine (Baltimore) 2018; 97: e10717.","DOI":"10.1097\/MD.0000000000010717"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.nrl.2022.08.001","article-title":"Cerebellar hypermetabolism: an alternative marker for diagnosis of paraneoplastic cerebellar degeneration","volume":"38","author":"Arslan","year":"2023","unstructured":"Arslan D, Ardic FS, Gultekin-Zaim OB, Tuncel M, Kertmen N, Gocmen R, Yildiz FG and Tan E. Cerebellar hypermetabolism: an alternative marker for diagnosis of paraneoplastic cerebellar degeneration. Neurologia (Engl Ed) 2023; 38: 443-446.","journal-title":"Neurologia (Engl Ed)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2169\/internalmedicine.0738-22","article-title":"Paraneoplastic cerebellar degeneration accompanied by seropositivity for anti-GAD65, anti-SOX-1 and anti-VGCC antibodies due to small-cell lung cancer","volume":"63","author":"Takahashi","year":"2024","unstructured":"Takahashi N, Igari R, Iseki C, Kawahara H, Suzuki D, Suzuki Y, Sato H, Koyama S, Kobayashi M and Ohta Y. Paraneoplastic cerebellar degeneration accompanied by seropositivity for anti-GAD65, anti-SOX-1 and anti-VGCC antibodies due to small-cell lung cancer. Intern Med 2024; 63: 857-860.","journal-title":"Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Kollmer J, Bendszus M and Pham M. MR neurography: diagnostic imaging in the PNS. Clin Neuroradiol 2015; 25 Suppl 2: 283-289.","DOI":"10.1007\/s00062-015-0412-0"},{"key":"ref5","unstructured":"Gabriel JM, Erne B, Miescher GC, Ulrich J, Vital C and Steck AJ. Expression patterns of human PNS myelin proteins in neuropathies associated with anti-myelin antibodies. Schweiz Arch Neurol Psychiatr (1985) 1994; 145: 22-23."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1159\/000519969","article-title":"Paraneoplastic cerebellar degeneration with Anti-CV2\/CRMP5 antibodies in ovarian cancer: case report and review of the literature","volume":"14","author":"Juarez-Vignon Whaley","year":"2021","unstructured":"Juarez-Vignon Whaley JJ, Carrera-Muinos A, Hernandez-Gutierrez KG, Rodriguez-Cid JR, Otero-Cerdeira ME and Garcia-Montes V. Paraneoplastic cerebellar degeneration with Anti-CV2\/CRMP5 antibodies in ovarian cancer: case report and review of the literature. Case Rep Oncol 2021; 14: 1799-1805.","journal-title":"Case Rep Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","unstructured":"Graus F, Vincent A, Pozo-Rosich P, Sabater L, Saiz A, Lang B and Dalmau J. Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol 2005; 165: 166-171.","journal-title":"J Neuroimmunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","article-title":"Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management","volume":"58","author":"Rahimy","year":"2013","unstructured":"Rahimy E and Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol 2013; 58: 430-458.","journal-title":"Surv Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1173484","DOI":"10.3389\/fimmu.2023.1173484","article-title":"Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies","volume":"14","author":"Arnaldos-Perez","year":"2023","unstructured":"Arnaldos-Perez C, Vilaseca A, Naranjo L, Sabater L, Dalmau J, Ruiz-Garcia R and Graus F. Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies. Front Immunol 2023; 14: 1173484.","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2169\/internalmedicine.0168-22","article-title":"Anti-SOX1 antibody-positive small-cell lung cancer that triggered opsoclonus","volume":"62","author":"Chiko","year":"2023","unstructured":"Chiko Y, Sugisaki Y, Miyoshi K, Morichika D, Beika Y, Taniguchi A, Ichihara E and Okada T. Anti-SOX1 antibody-positive small-cell lung cancer that triggered opsoclonus. Intern Med 2023; 62: 881-884.","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/JPR.S349101","article-title":"60-day PNS treatment may improve identification of delayed responders and delayed non-responders to neurostimulation for pain relief","volume":"15","author":"Naidu","year":"2022","unstructured":"Naidu R, Li S, Desai MJ, Sheth S, Crosby ND and Boggs JW. 60-day PNS treatment may improve identification of delayed responders and delayed non-responders to neurostimulation for pain relief. J Pain Res 2022; 15: 733-743.","journal-title":"J Pain Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mcn.2017.11.004","article-title":"Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment","volume":"86","author":"Monfrini","year":"2018","unstructured":"Monfrini M, Ravasi M, Maggioni D, Donzelli E, Tredici G, Cavaletti G and Scuteri A. Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment. Mol Cell Neurosci 2018; 86: 16-24.","journal-title":"Mol Cell Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-12-823912-4.00015-3","article-title":"Overview of treatment strategies in paraneoplastic neurological syndromes","volume":"200","author":"Kerstens","year":"2024","unstructured":"Kerstens J and Titulaer MJ. Overview of treatment strategies in paraneoplastic neurological syndromes. Handb Clin Neurol 2024; 200: 97-112.","journal-title":"Handb Clin Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/biomedicines11051406","article-title":"Paraneoplastic neurological syndromes of the central nervous system: pathophysiology, diagnosis, and treatment","volume":"11","author":"Marsili","year":"2023","unstructured":"Marsili L, Marcucci S, LaPorta J, Chirra M, Espay AJ and Colosimo C. Paraneoplastic neurological syndromes of the central nervous system: pathophysiology, diagnosis, and treatment. Biomedicines 2023; 11: 1406.","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Bastiaansen AEM, de Jongste AHC, de Bruijn M, Crijnen YS, Schreurs MWJ, Verbeek MM, Dumoulin DW, Taal W, Titulaer MJ and Sillevis Smitt PAE. Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes. Neurooncol Adv 2021; 3: vdab145.","DOI":"10.1093\/noajnl\/vdab145"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/jnnp-2017-316904","article-title":"Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies","volume":"89","author":"Berzero","year":"2018","unstructured":"Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanche JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY and Psimaras D. Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies. J Neurol Neurosurg Psychiatry 2018; 89: 789-792.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Giometto B, Vitaliani R, Lindeck-Pozza E, Grisold W and Vedeler C. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 2012; 12: CD007625.","DOI":"10.1002\/14651858.CD007625.pub2"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.2169\/internalmedicine.51.6884","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis with esophageal small cell carcinoma","volume":"51","author":"Shirafuji","year":"2012","unstructured":"Shirafuji T, Kanda F, Sekiguchi K, Higuchi M, Yokozaki H, Tanaka K, Takahashi H and Toda T. Anti-Hu-associated paraneoplastic encephalomyelitis with esophageal small cell carcinoma. Intern Med 2012; 51: 2423-2427.","journal-title":"Intern Med"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/4\/ajtr0157429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:22Z","timestamp":1766022922000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/4\/ajtr0157429.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/nhtj8584","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}